User profiles for Markus Riester
Markus RiesterNovartis Institutes for Biomedical Research Verified email at novartis.com Cited by 7767 |
[PDF][PDF] Specific effects of microRNAs on the plant transcriptome
Most plant microRNAs (miRNAs) have perfect or near-perfect complementarity with their
targets. This is consistent with their primary mode of action being cleavage of target mRNAs, …
targets. This is consistent with their primary mode of action being cleavage of target mRNAs, …
Highly Specific Gene Silencing by Artificial MicroRNAs in Arabidopsis
Plant microRNAs (miRNAs) affect only a small number of targets with high sequence
complementarity, while animal miRNAs usually have hundreds of targets with limited …
complementarity, while animal miRNAs usually have hundreds of targets with limited …
Genetic mechanisms of target antigen loss in CAR19 therapy of acute lymphoblastic leukemia
…, X Han, C Tribouley, PA Wood, RJ Leary, M Riester… - Nature medicine, 2018 - nature.com
We identified genetic mutations in CD19 and loss of heterozygosity at the time of CD19 –
relapse to chimeric antigen receptor (CAR) therapy. The mutations are present in the vast …
relapse to chimeric antigen receptor (CAR) therapy. The mutations are present in the vast …
[HTML][HTML] Most human non-GCIMP glioblastoma subtypes evolve from a common proneural-like precursor glioma
To understand the relationships between the non-GCIMP glioblastoma (GBM) subgroups, we
performed mathematical modeling to predict the temporal sequence of driver events during …
performed mathematical modeling to predict the temporal sequence of driver events during …
JAK–STAT pathway activation in malignant and nonmalignant cells contributes to MPN pathogenesis and therapeutic response
The identification of JAK2/MPL mutations in patients with myeloproliferative neoplasms (MPN)
has led to the clinical development of JAK kinase inhibitors, including ruxolitinib. …
has led to the clinical development of JAK kinase inhibitors, including ruxolitinib. …
Combination of a novel gene expression signature with a clinical nomogram improves the prediction of survival in high-risk bladder cancer
M Riester, JM Taylor, A Feifer, T Koppie… - Clinical cancer …, 2012 - AACR
Purpose: We aimed to validate and improve prognostic signatures for high-risk urothelial
carcinoma of the bladder. Experimental Design: We evaluated microarray data from 93 patients …
carcinoma of the bladder. Experimental Design: We evaluated microarray data from 93 patients …
Risk prediction for late-stage ovarian cancer by meta-analysis of 1525 patient samples
Background Ovarian cancer causes more than 15000 deaths per year in the United States.
The survival of patients is quite heterogeneous, and accurate prognostic tools would help …
The survival of patients is quite heterogeneous, and accurate prognostic tools would help …
[HTML][HTML] TGFβ-blockade uncovers stromal plasticity in tumors by revealing the existence of a subset of interferon-licensed fibroblasts
Despite the increasing interest in targeting stromal elements of the tumor microenvironment,
we still face tremendous challenges in developing adequate therapeutics to modify the …
we still face tremendous challenges in developing adequate therapeutics to modify the …
[HTML][HTML] curatedOvarianData: clinically annotated data for the ovarian cancer transcriptome
This article introduces a manually curated data collection for gene expression meta-analysis
of patients with ovarian cancer and software for reproducible preparation of similar …
of patients with ovarian cancer and software for reproducible preparation of similar …
Evolution of the cancer genome
Human tumors result from an evolutionary process operating on somatic cells within tissues,
whereby natural selection operates on the phenotypic variability generated by the …
whereby natural selection operates on the phenotypic variability generated by the …